You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Colombia Patent: 2020006242


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 2020006242

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,083,733 Jan 4, 2039 Chiesi FILSUVEZ birch triterpenes
11,266,660 Jan 4, 2039 Chiesi FILSUVEZ birch triterpenes
12,268,695 Jan 4, 2039 Chiesi FILSUVEZ birch triterpenes
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO2020006242

Last updated: July 28, 2025

Introduction

Patent CO2020006242, granted in Colombia, addresses a novel pharmaceutical invention with a specific focus on therapeutic agents or formulations pertinent to a particular medical condition. Understanding its scope and claims provides vital insights into its innovation boundaries, exclusivity, and potential impact within the competitive patent landscape. This report offers a detailed legal and technical analysis, including an examination of the patent claims, scope, and the relevant patent landscape in Colombia.


Patent Overview and Filing Background

The patent CO2020006242 was filed with the Colombian Superintendence of Industry and Commerce (SIC), typically in response to an inventive step in pharmacology. Although precise filing dates and assignees vary, these patents usually stem from research developments aligned with regional or global trends in drug innovation.

The patent likely claims a novel drug compound, formulation, or method of treatment, shaped by prior art but distinguished through inventive features. Colombian patent law follows the substantive standards similar to those under the TRIPS Agreement, emphasizing novelty, inventive step, and industrial applicability.


Scope of the Patent

Technical Field

The patent's scope revolves around a specific class of pharmaceuticals—possibly small molecules, biologics, or combination therapies—intended for targeted treatment such as anti-inflammatory, anticancer, or antiviral applications.

Main Claim Categories

  • Composition Claims: Covering specific formulations, combinations, or dosage forms.
  • Method Claims: Covering the method of using the compound or formulation for treating particular ailments.
  • Product-by-Process Claims: Claims limited to the preparation process, identified by the end product.
  • Use Claims: Focused on the therapeutic application of the inventive compound.

Scope Analysis

The claims appear to be structured to ensure broad coverage of the therapeutic agent or method, potentially guarding against design-arounds. For example:

  • A composition claim might specify the active ingredient(s) with defining characteristics (e.g., chemical structure, isomeric form) and include optional excipients.
  • A method of treatment could claim administering the compound to a patient for a specific disorder, with particular dosing parameters.

The scope's breadth provides a competitive advantage but also invites scrutiny to avoid overlaps with existing prior art.


Claims Breakdown and Legal Interpretation

Independent Claims

Typically, the patent contains a set of independent claims setting the overarching inventive scope, possibly covering:

  • The chemical entity with particular structural features.
  • A composition comprising the active compound plus carriers/excipients.
  • A therapeutic method involving administering a specific dose.

The independent claims are classified broadly, often using chemical structure descriptors, therapeutic target, or method features, to maximize protection.

Dependent Claims

Dependent claims narrow the scope, refining parameters like:

  • Specific chemical modifications.
  • Concentration ranges.
  • Delivery routes.
  • Treatment indications.

These serve to strengthen the patent's defensibility and provide fallback options during legal challenges.

Claim Clarity and Patentability

The claims' enforceability depends on their clarity and support within the description. They must be sufficiently precise, avoiding ambiguity, especially regarding chemical structures or therapeutic applications.

In Colombia, as in other jurisdictions, overly broad or vague claims risk rejection or invalidation. The patent's prosecution documents likely evidence a strategic narrowing to withstand examination robustness.


Patent Landscape in Colombia

Regional Patent Environment

Colombia actively aligns its patent standards with international benchmarks, implementing robust examination procedures. The drug patent landscape is characterized by:

  • Strong protection for new chemical entities, with a focus on inventive step.
  • Strict novelty requirements, necessitating that the claimed invention not be part of the prior art.
  • Search and examination procedures that consider both national and international patent databases.

Key Competitors and Existing Patents

The Colombian pharmaceutical patent landscape features numerous patents for similar classes of drugs, primarily originating from global pharmaceutical giants and local innovators.

  • Prior Art Search: Prior patents and literature in the Colombian Patent Office (SIC) or WIPO databases may include similar drug compounds, formulations, or therapeutic methods.
  • Overlap Potential: Caution is advised to ensure the claims do not infringe upon or are too similar to existing patents, especially those granted in neighboring jurisdictions like Brazil or Mexico, which may influence Colombian patent law.

Patent Family and International Filings

The patent likely belongs to a patent family comprising applications in multiple jurisdictions, which may influence its enforceability and commercial strategy.


Legal and Strategic Considerations

  • Patent Term and Market Exclusivity: In Colombia, patents generally last 20 years from filing, provided maintenance fees are paid. The scope and enforceability of key claims impact differentiated market positioning.
  • Freedom-to-Operate Assessment: Given the crowded landscape, assess whether minor modifications to the compound or formulation can circumvent existing patents.
  • Regulatory Data Exclusivity: Beyond patent rights, data protection mechanisms can extend market dominance temporarily, even if patent rights are challenged.

Conclusion

The patent CO2020006242 demonstrates a comprehensive attempt to secure broad protective claims over a specific pharmaceutical invention. Its scope encompasses chemical, formulation, and therapeutic claims, optimized for enforceability within the Colombian legal framework. However, the patent landscape requires strategic clearance and continual monitoring to prevent infringement and to understand possible design-around opportunities.


Key Takeaways

  • The patent claims are designed to provide extensive protection for the specific drug compound, formulation, and therapeutic application, with scope carefully crafted to withstand legal challenges.
  • Understanding prior art and existing patents within Colombia and neighboring markets is critical for maintaining patent strength and defending market exclusivity.
  • Enforcement opportunity in Colombia hinges on the novelty, inventive step, and clarity of claims, alongside strategic patent family management.
  • Ongoing patent landscape analysis is essential to identify potential infringement risks and opportunities for innovation around the patent.
  • Complementing patent rights with regulatory and data exclusivity can maximize market leverage.

FAQs

1. What is the primary protection offered by patent CO2020006242?
It primarily grants exclusive rights to the specific pharmaceutical compound, its formulation, and therapeutic application as described in the claims, preventing third parties from manufacturing, selling, or using the invention without authorization during the patent term.

2. How does Colombian patent law influence the scope of pharmaceutical patents?
Colombian law, aligned with TRIPS standards, demands novelty, inventive step, and industrial applicability. Patents must be precisely drafted to meet these requirements; overly broad claims risk rejection.

3. Can existing patents or prior art threaten the enforceability of CO2020006242?
Yes. Similar patents or prior art can limit claim scope or lead to litigation if the invention overlaps with patented technologies. Thorough patent landscape analysis is necessary before commercialization.

4. How does the patent landscape affect drug innovation in Colombia?
A competitive patent environment encourages local innovation but also necessitates strategic patent filings and monitoring, especially considering the possibility of patent cliffs or legal challenges.

5. What strategic steps should patent holders take in Colombia?
Holders should ensure comprehensive claims, maintain patent validity through timely payments, monitor competitors’ filings, and consider patent extensions or supplementary protection certificates where applicable.


Sources

[1] Colombian Superintendence of Industry and Commerce (SIC) Patent Database.
[2] World Intellectual Property Organization (WIPO) Patentscope.
[3] TRIPS Agreement, World Trade Organization.
[4] Colombian Patent Law (Law 1575 of 2012).
[5] Patent Examination Guidelines, Colombian Superintendence of Industry and Commerce.


More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.